Tag: Pharmaceutical
New Enflex brand series from Volpak
Volpak, a Coesia company, is launching a new Enflex brand series for the pharmaceutical and healthcare market – the Enflex PHS Series that comes...
Artificial intelligence in the world of cosmetics
The SEA Vision Group will be at the Marchesini Group's beauty stand (A/9PK) at the Cosmopack show in Bologna from 16 to 18 March...
Shubham Automation – mastering the art of pick and place
Cosmetics and medical drugs have become part of our daily lives, with everyone carrying little boxes in their pockets, purses, or bags. No doubt,...
US FDA bid to strengthen drug supply chain
27 November 2023 is the US Food and Drug Administration's (FDA) deadline for compliance with the Drug Supply Chain Security Act (DSCSA), which aims...
Optima Group completes 100 years
In 2022, the Optima Group celebrated its 100th anniversary in Schwaebisch Hall, Germany – looking back on a century of innovation, expansion, partnership, and...
Covid-19 scare: Govt tells pharma cos to maintain stocks
In the wake of the global rise in Covid-19 cases, the Indian government has asked pharma companies to ensure adequate stocks of all drugs,...
Marchesini Group acquires Rejves Machinery by the end of 2022
The year 2022 had ended with a new acquisition by Marchesini Group, which has taken over Rejves Machinery Srl, a company from Marmirolo (Mantua)...
Airnov launches HAT-B innovative vial
Airnov Healthcare Packaging, a global provider in controlled atmosphere packaging, continues to enhance its offering to customers with additions to its portfolio.
Launched in July...
AIPIA Congress highlight – Cleantech and Beyond’s DTI
One of the new products on show at the AIPIA World congress in Amsterdam in November, was Cleantech’s Digital Temperature Indicator (DTI), an irreversible...
Alzheimer’s drug lecanemab slows cognitive decline in clinical trial
Eisai, a Japanese pharmaceutical company headquartered in Tokyo, and American multinational Biogen have released the results from their phase III clinical trial of lecanemab,...